Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + cisplatin with Bojungikgi-tang for metastatic or progressive bile duct carcinoma
KCT0001884Phase 4Recruiting
- Sponsor
- Comprehensive & Integrative Medicine Institute
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gemcitabine, cisplatin in cholangiocarcinoma (CCA), sponsored by Comprehensive & Integrative Medicine Institute. Started Mar 2016; status: recruiting.
02
Drugs
gemcitabinecisplatin
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on KCT0001884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001884.